RecruitingNCT06899867

Comparing Montiroing Cardiac Index by Transpulmonary Thermodilution and Transesophageal Echocardiography During Liver Transplantation

Is Cardiac Index, Assessed by Transpulmonary Thermodilution, Reliable During Liver Transplantation Compared to Transesophageal Echocardiography : a Monocentric Cohort


Sponsor

Hospices Civils de Lyon

Enrollment

30 participants

Start Date

Nov 27, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Liver transplantation poses challenges due to hemodynamic changes throughout different surgical phases. Monitoring devices are essential for therapeutic adjustments. Transpulmonary thermodilution and transesophageal echocardiography are commonly used, but thermodilution may have limitations depending on the surgery. This study aims to compare cardiac index variations between thermodilution and transesophageal echocardiography during liver transplantation. Patients undergo monitoring with both techniques. Measurements are recorded and reported at multiple time points.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • liver transplantation
  • adults

Exclusion Criteria4

  • \- Oesophageal varice ligation < 14 days
  • Mediastinal radiotherapy
  • Femoral bypass
  • Severe lower extremity artery disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMeasure of cardiac index with thermodilution and transesophageal echocardiography

At 4 times of surgery, end-expiratory occlusion (EEO) test and measure of cardiac index before and after test with ETO and thermodilution

OTHERSurgical anastomosis echography

Visualisation of surgical anastomosis through transesophageal echocardiography : stenosis, doppler velocity, collar diameter


Locations(1)

Croix Rousse Hsopital

France, Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06899867


Related Trials